Akoya Biosciences (AKYA) Short Interest Ratio & Short Volume → is this a buy and hold stock? (From Tips4Traders) (Ad) Free AKYA Stock Alerts $2.90 -1.22 (-29.61%) (As of 05/14/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Akoya Biosciences Short Interest DataCurrent Short Volume1,040,000 sharesPrevious Short Volume1,010,000 sharesChange Vs. Previous Month+2.97%Dollar Volume Sold Short$3.97 millionShort Interest Ratio / Days to Cover6.3Last Record DateApril 30, 2024Outstanding Shares49,380,000 sharesFloat Size21,410,000 sharesShort Percent of Float4.86%Today's Trading Volume2,207,943 sharesAverage Trading Volume134,561 sharesToday's Volume Vs. Average1,641% Short Selling Akoya Biosciences ? Sign up to receive the latest short interest report for Akoya Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatAKYA Short Interest Over TimeAKYA Days to Cover Over TimeAKYA Percentage of Float Shorted Over Time Ad Tips4Tradersis this a buy and hold stock?“Simply Wall Street” LOVES this stock as a Buy and Hold. It’s surging now! ….Click here to learn more Akoya Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20241,040,000 shares $3.97 million +3.0%4.9%6.3 $3.82 4/15/20241,010,000 shares $4.05 million +2.2%4.7%5.6 $4.01 3/31/2024988,400 shares $4.64 million -5.9%4.7%4.8 $4.69 3/15/20241,050,000 shares $5.16 million +25.7%4.9%5.2 $4.91 2/29/2024835,500 shares $4.80 million +8.1%3.9%4 $5.74 2/15/2024773,200 shares $4.50 million +5.3%3.6%4 $5.82 Get the Latest News and Ratings for AKYA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Akoya Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024734,600 shares $3.73 million +2.5%3.3%4 $5.08 1/15/2024716,800 shares $3.71 million +13.6%3.2%4.3 $5.18 12/31/2023631,000 shares $3.08 million -17.6%2.8%4.1 $4.88 12/15/2023765,300 shares $3.40 million -13.8%3.4%5.3 $4.44 11/30/2023887,600 shares $3.90 million -10.0%4.0%5.8 $4.39 11/15/2023986,100 shares $4.39 million -18.5%4.4%6.6 $4.45 10/31/20231,210,000 shares $4.24 million +16.4%5.4%7.6 $3.50 10/15/20231,040,000 shares $3.72 million +9.6%4.7%6.5 $3.58 9/30/2023949,100 shares $4.41 million +24.2%4.3%6.1 $4.65 9/15/2023764,200 shares $3.32 million +14.4%3.4%4.9 $4.34 8/31/2023668,100 shares $3.47 million +1.8%3.1%3 $5.20 8/15/2023656,200 shares $3.63 million -4.1%3.1%2.6 $5.53 7/31/2023684,500 shares $4.72 million -5.8%3.2%2.8 $6.90 7/15/2023726,700 shares $5.07 million +5.5%3.4%3 $6.98 6/30/2023688,900 shares $5.09 million 0.0%3.3%2.9 $7.39 6/15/2023689,200 shares $5.75 million -0.4%3.3%3 $8.35 5/31/2023691,800 shares $3.89 million +1.7%4.1%4.1 $5.63 5/15/2023680,000 shares $3.94 million +1.0%4.0%5.9 $5.80 4/30/2023673,300 shares $4.69 million +2.6%4.0%6 $6.96 4/15/2023656,500 shares $4.62 million +56.0%3.9%5.8 $7.04 3/31/2023420,900 shares $3.44 million -41.8%2.5%3.5 $8.18 3/15/2023722,700 shares $6.15 million +45.1%4.3%5.5 $8.51 2/28/2023498,000 shares $5.74 million +3.0%2.9%4.4 $11.53 2/15/2023483,400 shares $6.01 million -4.1%2.8%3.8 $12.43 1/31/2023503,800 shares $5.67 million -11.9%3.0%3.9 $11.25 1/15/2023571,500 shares $6.16 million -5.2%3.4%4.5 $10.78 12/30/2022602,700 shares $5.77 million +22.2%3.5%4.9 $9.57 12/15/2022493,400 shares $6.05 million -68.0%2.9%4.1 $12.26 11/30/20221,540,000 shares $19.99 million -7.2%9.0%10.4 $12.98 11/15/20221,660,000 shares $21.63 million -8.3%9.7%12 $13.03 10/31/20221,810,000 shares $24.89 million -4.2%10.6%12.6 $13.75 10/15/20221,890,000 shares $22.08 million -2.1%11.1%13.1 $11.68 9/30/20221,930,000 shares $22.68 million +1.1%11.3%11.8 $11.75 9/15/20221,910,000 shares $24.56 million +147.4%11.2%10.9 $12.86is this a buy and hold stock? (Ad)“Simply Wall Street” LOVES this stock as a Buy and Hold. It’s surging now! ….Click here to learn more AKYA Short Interest - Frequently Asked Questions What is Akoya Biosciences' current short interest? Short interest is the volume of Akoya Biosciences shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 1,040,000 shares of AKYA short. 4.86% of Akoya Biosciences' shares are currently sold short. Learn More on Akoya Biosciences' current short interest. What is a good short interest ratio for Akoya Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AKYA shares currently have a short interest ratio of 6.0. Learn More on Akoya Biosciences's short interest ratio. Which institutional investors are shorting Akoya Biosciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Akoya Biosciences: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Akoya Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.86% of Akoya Biosciences' floating shares are currently sold short. Is Akoya Biosciences' short interest increasing or decreasing? Akoya Biosciences saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 1,040,000 shares, an increase of 3.0% from the previous total of 1,010,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Akoya Biosciences' float size? Akoya Biosciences currently has issued a total of 49,380,000 shares. Some of Akoya Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Akoya Biosciences currently has a public float of 21,410,000 shares. How does Akoya Biosciences' short interest compare to its competitors? 4.86% of Akoya Biosciences' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Akoya Biosciences: Prelude Therapeutics Incorporated (2.43%), Seer, Inc. (7.09%), Sutro Biopharma, Inc. (3.12%), Athira Pharma, Inc. (2.97%), Bionano Genomics, Inc. (7.79%), Nautilus Biotechnology, Inc. (1.96%), Pacific Biosciences of California, Inc. (19.39%), Arbutus Biopharma Co. (3.08%), EyePoint Pharmaceuticals, Inc. (12.67%), Quanterix Co. (3.84%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Akoya Biosciences stock? Short selling AKYA is an investing strategy that aims to generate trading profit from Akoya Biosciences as its price is falling. AKYA shares are trading down $1.22 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Akoya Biosciences? A short squeeze for Akoya Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AKYA, which in turn drives the price of the stock up even further. How often is Akoya Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AKYA, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Seer Short Squeeze Prelude Therapeutics Short Squeeze Athira Pharma Short Squeeze Bionano Genomics Short Squeeze Prenetics Global Short Squeeze Sutro Biopharma Short Squeeze Nautilus Biotechnology Short Squeeze TELA Bio Short Squeeze Syros Pharmaceuticals Short Squeeze Sagimet Biosciences Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AKYA) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill Publishingis this a buy and hold stock?Tips4TradersWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersBiden to Drop BOMBSHELL June 13th?Paradigm Press